News
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
24 Apr 24
News, Pre-Market Outlook, Markets, Movers
AiBtl BioPharma Inc. Acquired TT Life Company, Valued At $8.33M, With 1.66M AiBtl Shares At $5 per Share
18 Apr 24
M&A
ABVC BioPharma Executes A Global Licensing Definitive Agreement For The Treatment Of NSCLC, Expecting Aggregate Income Of $13.75M And Royalties Of Up To $12.50M
17 Apr 24
Biotech, News, Contracts, General
12 Health Care Stocks Moving In Wednesday's After-Market Session
10 Apr 24
Movers
Market-Moving News for April 10th
10 Apr 24
Movers, Trading Ideas
ABVC BioPharma Executes A Global Licensing Term Sheet For Oncology/Hematology Products, Expecting Licensing Income Of $55M And Royalties Of Up To $50M
10 Apr 24
News, Guidance, Contracts
12 Health Care Stocks Moving In Monday's After-Market Session
1 Apr 24
Movers
Why ABVC BioPharma Stock Is Up Today
26 Mar 24
News, Penny Stocks, Movers
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
26 Mar 24
Movers
ABVC BioPharma Provides Fiscal Year 2024 Q1 Business Update
14 Mar 24
News, Guidance
ABVC's New Horizon For Oncology And Hematology Aims At Cancer Market
27 Feb 24
Biotech, News, General
Press releases
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
18 Apr 24
Press Releases
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
10 Apr 24
Press Releases
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
26 Mar 24
Press Releases
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
14 Mar 24
Earnings, Press Releases
ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)
12 Feb 24
News, Legal, Press Releases
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
8 Feb 24
Press Releases